Mirabegron: A Beta-3 Agonist for Overactive Bladder

The Consultant Pharmacist
doi 10.4140/tcp.n.2014.823
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Consultant Pharmacists

Related search

Mirabegron &Ndash; A Selective &Szlig;3-Adrenoreceptor Agonist for the Treatment of Overactive Bladder

Research and Reports in Urology
Urology
2012English

Persistence and Adherence With Mirabegron, a New Beta-3 Receptor Agonist, Versus Antimuscarinics in Overactive Bladder: Early Experience in Canada

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Discovery of Vibegron: A Potent and Selective 3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

English

New Developments in the Management of Overactive Bladder: Focus on Mirabegron and onabotulinumtoxinA

Therapeutics and Clinical Risk Management
2013English

The Effect of Mirabegron, Used for Overactive Bladder Treatment, on Female Sexual Function: A Prospective Controlled Study

BMC Urology
MedicineReproductive MedicineUrology
2018English

Effectiveness of an Intervention to Optimise the Use of Mirabegron for Overactive Bladder: A Quasi-Experimental Study in Primary Care

British Journal of General Practice
MedicineFamily Practice
2018English

Efficacy and Tolerability of Mirabegron in Female Patients With Overactive Bladder Symptoms After Surgical Treatment for Stress Urinary Incontinence

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2019English

Refractory Overactive Bladder: A Common Problem?

International Urogynecology Journal
GynecologyUrologyObstetrics
2015English

Factors Associated With Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE)

Advances in Therapy
MedicinePharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy